You are here

In Vitro Model for Dermal Irritation

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 22411
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 1993
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
200 Homer Avenue
Ashland, MA 01721
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Joseph Kubilus
 (508) 881-6771
Business Contact
Phone: () -
Research Institution

In order to protect the general public from a broad variety of potentially harmful products and chemicals, toxicologic testing for dermal irritancy is routinely performed using laboratory animals. However, the use of animals and their maintenance is becoming increasingly costly. Animal testing suffers from subjectivity, high variability, and the flaw of applying data obtained with animals to humans persists. In addition, there is increasing public opinion that favors reduction or elimination of animal subjects for any cosmetic, industrial, or medical testing. Thus, non-animal, "in vitro" alternative tests are being sought. We will model dermal irritation and inflammation using normal human epidermal keratinocytes which have been cultured to form a highly differentiated, stratified epidermis-like tissue. By measuring the release of the molecular mediators which start the physiological cascade leading to dermal irritation in vivo , it is hypothesized that this "in vitro" system could predict the dermal irritancy potential of a particular compound. This system will allow one to accomplish this in a rapid, cost effective, and reproducible manner without the use of laboratory animals.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government